| Bioactivity | PF-05241328 is a potent and selective inhibitor of human Nav1.7 voltage-dependent sodium channels (Nav1.7), with an IC50 of 31 nM. | |||||||||
| Target | IC50: 31 nM (Nav1.7). | |||||||||
| Name | PF-05241328 | |||||||||
| CAS | 1387633-03-5 | |||||||||
| Formula | C19H21ClN4O4S | |||||||||
| Molar Mass | 436.91 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Jones HM, et al. Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels. Clin Pharmacokinet. 2016 Jul;55(7):875-887. |
PF-05241328
CAS: 1387633-03-5 F: C19H21ClN4O4S W: 436.91
PF-05241328 is a potent and selective inhibitor of human Nav1.7 voltage-dependent sodium channels (Nav1.7), with an IC50
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.